Company profile PLRX

Pliant Therapeutics Inc
pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-β modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disea...se to both increase understanding of natural disease progression, and fuel biomarker discovery. pliant’s co-founders include world-renowned researchers from university of california, san francisco (ucsf), who bring broad experience in fibrosis biology and small molecule chemistry. together, the pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need. Show More
Quarter analysis & expected interestLast update: February 09 2024 18:01:37.

After 39 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 52 days it will total up to 100.0.
Pliant Therapeutics expected interest is significantly lower compared to same quarter last year (-52.2%) but higher than previous quarter (+40.8%).

YearQ1Q2Q3Q4
201952
76
46.2% QoQ
32
-57.9% QoQ
29
-9.4% QoQ
2020 56
7.7% YoY 93.1% QoQ
182
139.5% YoY 225.0% QoQ
88
175.0% YoY -51.6% QoQ
26
-10.3% YoY -70.5% QoQ
2021 78
39.3% YoY 200.0% QoQ
41
-77.5% YoY -47.4% QoQ
65
-26.1% YoY 58.5% QoQ
12
-53.8% YoY -81.5% QoQ
2022 115
47.4% YoY 858.3% QoQ
96
134.1% YoY -16.5% QoQ
206
216.9% YoY 114.6% QoQ
126
950.0% YoY -38.8% QoQ
2023 209
81.7% YoY 65.9% QoQ
102
6.2% YoY -51.2% QoQ
108
-47.6% YoY 5.9% QoQ
71
-43.7% YoY -34.3% QoQ
2024 43
-79.4% YoY -39.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Pliant Therapeutics search interestLast update: February 09 2024 18:01:36.
Correlation coefficient between keyword and revenue is -0.2
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:01:39.

The average 5 years interest of Pliant Therapeutics was 6.95 per week.
The last year interest of Pliant Therapeutics compared to the last 5 years has changed by 24.03%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 114.43%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:01:46.

After 39 days of this quarter the interest is at 54.0. Based on that we can calculate that during remaining 52 days it will total up to 126.0.
Pliant Therapeutics stock expected interest is significantly lower compared to same quarter last year (-43.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
201978
59
-24.4% QoQ
0
-100.0% QoQ
39
inf% QoQ
2020 93
19.2% YoY 138.5% QoQ
212
259.3% YoY 128.0% QoQ
136
inf% YoY -35.8% QoQ
102
161.5% YoY -25.0% QoQ
2021 85
-8.6% YoY -16.7% QoQ
94
-55.7% YoY 10.6% QoQ
113
-16.9% YoY 20.2% QoQ
152
49.0% YoY 34.5% QoQ
2022 146
71.8% YoY -3.9% QoQ
76
-19.1% YoY -47.9% QoQ
178
57.5% YoY 134.2% QoQ
96
-36.8% YoY -46.1% QoQ
2023 221
51.4% YoY 130.2% QoQ
112
47.4% YoY -49.3% QoQ
49
-72.5% YoY -56.2% QoQ
113
17.7% YoY 130.6% QoQ
2024 54
-75.6% YoY -52.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Pliant Therapeutics stock search interestLast update: February 09 2024 18:01:46.
Correlation coefficient between keyword and revenue is -0.18
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:01:47.

The average 5 years interest of Pliant Therapeutics stock was 8.46 per week.
The last year interest of Pliant Therapeutics stock compared to the last 5 years has changed by 10.87%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 112.22%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics bexotegrast to provide analysis

Correlation between past revenue and Pliant Therapeutics bexotegrast search interest

There is not enough data for Pliant Therapeutics bexotegrast to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics bexotegrast to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics fibrosis treatment to provide analysis

Correlation between past revenue and Pliant Therapeutics fibrosis treatment search interest

There is not enough data for Pliant Therapeutics fibrosis treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics fibrosis treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics avß6 inhibitor to provide analysis

Correlation between past revenue and Pliant Therapeutics avß6 inhibitor search interest

There is not enough data for Pliant Therapeutics avß6 inhibitor to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics avß6 inhibitor to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics liver fibrosis to provide analysis

Correlation between past revenue and Pliant Therapeutics liver fibrosis search interest

There is not enough data for Pliant Therapeutics liver fibrosis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics liver fibrosis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics muscular dystrophies to provide analysis

Correlation between past revenue and Pliant Therapeutics muscular dystrophies search interest

There is not enough data for Pliant Therapeutics muscular dystrophies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics muscular dystrophies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics South San Francisco to provide analysis

Correlation between past revenue and Pliant Therapeutics South San Francisco search interest

There is not enough data for Pliant Therapeutics South San Francisco to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics South San Francisco to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics contact to provide analysis

Correlation between past revenue and Pliant Therapeutics contact search interest

There is not enough data for Pliant Therapeutics contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Pliant Therapeutics clinical trials to provide analysis

Correlation between past revenue and Pliant Therapeutics clinical trials search interest

There is not enough data for Pliant Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Pliant Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for PLRX
Earnings date: 2024-03-07 After close
Company name: Pliant Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-11T20:05:00Z

GlobeNewswire
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

2026-05-06T12:30:00Z

GlobeNewswire
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

2026-04-30T12:30:00Z

GlobeNewswire
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

2026-04-18T17:31:00Z

GlobeNewswire
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

2026-03-13T18:27:35Z

Analyst Upgrades
Canaccord Genuity Maintains Hold on Pliant Therapeutics, Lowers Price Target to $3

2026-03-12T16:34:32Z

Analyst Upgrades
Piper Sandler Maintains Overweight on Pliant Therapeutics, Lowers Price Target to $3

2026-02-23T13:00:00Z

GlobeNewswire
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference

2025-12-04T12:30:00Z

GlobeNewswire
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

2025-12-01T13:30:00Z

GlobeNewswire
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

2025-11-07T19:19:06Z

Analyst Upgrades
RBC Capital Maintains Sector Perform on Pliant Therapeutics, Lowers Price Target to $2

2025-11-06T21:05:00Z

GlobeNewswire
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

2025-10-10T11:36:28Z

Analyst Upgrades
JP Morgan Downgrades Pliant Therapeutics to Underweight

2025-09-04T17:13:05-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - PLIANT THERAPEUTICS, INC. (0001746473) (Subject)

2025-08-08T11:28:12Z

Analyst Upgrades
Piper Sandler Maintains Overweight on Pliant Therapeutics, Lowers Price Target to $4

2025-08-07T16:22:31-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - PLIANT THERAPEUTICS, INC. (0001746473) (Filer)